A Real-World Evidence Study on U.S. Patients Demonstrating Safety of High-Frequency Use of the Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Real-World Evidence Study on U.S. Patients Demonstrating Safety of High-Frequency Use of the Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment

This real-world observational study evaluates the safety and tolerability of remote electrical neuromodulation (REN; Nerivio®) in patients who have utilized it more frequently than the current label indication for migraine treatment.

  • By

  • October 19, 2026

  • 2 min

Share

Original Source(s)

A Real-World Evidence Study on U.S. Patients Demonstrating Safety of High-Frequency Use of the Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment

  • by

  • October 19, 2026

Related Content

Advancing Precision Medicine for Pediatric Brain and Spinal Cord Tumors

Advances in molecular diagnostics are changing how clinicians diagnose and treat pediatric brain and spinal cord tumors.

  • by

  • October 8, 2026

  • 8 min
Daily-life dynamics of general and cognitive fatigue in childhood cancer survivors: An experience sampling and wearable study

Skin odor signatures may shift with age

Investigators linked distinct odor patterns to life stage, sex, and skin microbes, while limited longitudinal evidence leaves their clinical utility uncertain.